Search

Jing Y Watnick

from Chestnut Hill, MA
Age ~54
Get Report
Also known as:
Jing Y Ye
Phone and address:
280 Boylston St APT 111, Boston, MA 02467
(617) 244-3675
Related to:
Ofir Madar, 56Lilach MadarDavid Watnick, 97Siyu Liu, 61
Connected to:
Donald C Watnick, 85Randolph S Watnick, 53Amber R Watnik, 34Maurice Watome, 40Jacob S Wator, 63Vicki J Wator, 72Adrienne Watral, 38Cathy L Watral, 65Mikel A Watras, 45Charles R Watret, 87

Jing Watnick Phones & Addresses

  • 280 Boylston St APT 111, Chestnut Hill, MA 02467 (617) 244-3675
  • Allston, MA
  • 22 Bracebridge Rd, Newton Center, MA 02459 (617) 916-2112
  • Buffalo, NY
  • Cambridge, MA
  • Malden, MA
  • Groveland, MA
  • Evanston, IL
  • 22 Bracebridge Rd, Newton Center, MA 02459

Work

Company: Vigeo therapeutics Jun 2015 Position: Discovery and development of novel oncology therapeutics

Education

Degree: Master of Business Administration, Masters School / High School: Northwestern University - Kellogg School of Management

Skills

Pharmaceutical Industry • Biotechnology • Drug Discovery • Clinical Development • Lifesciences • Drug Development • Oncology • Technology Transfer • Commercialization • Clinical Trials • Regulatory Affairs • Cross Functional Team Leadership • Medical Devices • Infectious Diseases • Biomarkers • Clinical Research • Cro • Biopharmaceuticals • Translational Medicine • R&D • Biochemistry • Ctms • In Vitro • Molecular Biology • Program Management • Pharmacokinetics • Pharmacology • Regulatory Submissions • Strategy • Leadership • Management • Start Ups • Fda • Strategic Planning • Gcp • Clinical Trial Management System • Cro Management • Good Clinical Practice • Life Sciences • Research and Development • U.s. Food and Drug Administration

Industries

Pharmaceuticals

Resumes

Resumes

Jing Watnick Photo 1

Discovery And Development Of Novel Oncology Therapeutics

View page
Location:
Boston, MA
Industry:
Pharmaceuticals
Work:
Vigeo Therapeutics
Discovery and Development of Novel Oncology Therapeutics
Vigeo Therapeutics Nov 2014 - May 2015
Founding Chief Executive Officer
Tesaro, Inc. Jan 2014 - Nov 2014
Program Lead, Niraparib
Alexion Pharmaceuticals, Inc. 2012 - 2014
Program Leader and Portfolio Management
Novartis 2009 - Jan 2012
Global Program and Portfolio Lead, Oncology Bu
Education:
Northwestern University - Kellogg School of Management
Master of Business Administration, Masters Peking University
Bachelors, Bachelor of Science University at Buffalo
Doctorates, Doctor of Philosophy
Skills:
Pharmaceutical Industry
Biotechnology
Drug Discovery
Clinical Development
Lifesciences
Drug Development
Oncology
Technology Transfer
Commercialization
Clinical Trials
Regulatory Affairs
Cross Functional Team Leadership
Medical Devices
Infectious Diseases
Biomarkers
Clinical Research
Cro
Biopharmaceuticals
Translational Medicine
R&D
Biochemistry
Ctms
In Vitro
Molecular Biology
Program Management
Pharmacokinetics
Pharmacology
Regulatory Submissions
Strategy
Leadership
Management
Start Ups
Fda
Strategic Planning
Gcp
Clinical Trial Management System
Cro Management
Good Clinical Practice
Life Sciences
Research and Development
U.s. Food and Drug Administration
Control profile
Jing Y Watnick from Chestnut Hill, MA, age ~54 Get Report